Novo CEO pressed by Senate to cut prices of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would consider new talks with insurers with regard to the list selling prices of Wegovy and copyright when they pledge to maintain the medicines on their formularies. Don't miss https://daveshotchickennutrition96284.is-blog.com/37007927/5-simple-techniques-for-healthcare-news